Disclosed are dihydroindolone compounds which can modulate the activity of protein tyrosine kinases, a method for preparing the same, and pharmaceutical compositions comprising the same. Also disclosed are use of such compounds and pharmaceutical compositions thereof in the treatment and/or prophylaxis of protein tyrosine kinase associated diseases in an organism, particularly in the treatment and/or prophylaxis of tumors and fibroblast proliferation associated diseases.
本发明涉及二氢
吲哚酮化合物,其可以调节
蛋白酪氨酸激酶的活性,以及制备该化合物的方法和含有该化合物的药物组合物。本发明还涉及在有机体中治疗和/或预防与
蛋白酪氨酸激酶相关的疾病,特别是在治疗和/或预防肿瘤和成纤维细胞增殖相关疾病中使用这种化合物和药物组合物。